Jubilant Pharmova Limited (JUBLPHARMA)

1,213.45

INR
-13.65(-1.11%)
As of December 6, 2024 9:59:00 AM

Jubilant Pharmova Limited Share Price Information

24 hour Low and High

Low: 1193.1
High: 1233.4

All time High

9552.63

Price Change 1h

+₹-13.65 +-1.11%

Price Change 1d

+₹-13.65 +-1.11%

Price Change 1w

+₹44.70 +3.82%

Jubilant Pharmova Limited Market Information

Exchange

NSE

Market Cap

17931.33 Cr

About Jubilant Pharmova Limited Share

Jubilant Pharmova Limited operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally. It operates through six segments: Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research Development and Manufacturing Organisation; and Proprietary Novel Drugs. The Radiopharma segment offers radiopharmaceuticals products, which are used in the diagnosis and treatment of various diseases, including pulmonary embolism, cancer, coronary artery disease, and others. Its Allergy Immunotherapy segment provides specialised diagnostic devices for skin testing, as well as venom and allergy immunotherapy products. The Contract Development and Manufacturing Organisation - Sterile Injectables segment offers contract manufacturing services for sterile fill and finish injectables, liquids, ointments, creams, and ampoules. Its Generics segment engages in the development, manufacturing, distribution, sale, and marketing of generic formulations for therapeutic areas comprising cardiovascular system, central nervous system, gastrointestinal, antibiotics, and multispecialty. The Contract Research Development and Manufacturing Organisation segment offers drug discovery and development services and active pharmaceutical ingredients. The Proprietary Novel Drugs segment provides patient-focused biopharmaceutical services to address unmet medical needs in oncology and autoimmune diseases. It serves pharmaceutical, biotech, group purchasing organisations, allergists, and hospitals sectors. It sells its products through a network of dealers and distributors. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. The company was incorporated in 1978 and is based in Noida, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

5399

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Jubilant Pharmova (NSE:JUBLPHARMA) advances 8.1% this week, taking one-year gains to 157%
  • Jubilant Pharmova subsidiary gets VAI classification for Washington unit from USFDA, stock hits 52-week high
  • Jubilant Pharmova Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
  • Jubilant Pharmova Limited (NSE:JUBLPHARMA) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
  • Jubilant Pharmova Share Price Today - Jubilant Pharmova Stock Price Live NSE/BSE

FAQs

Jubilant Pharmova Limited (JUBLPHARMA)

1,213.45

INR
-13.65(-1.11%)
As of December 6, 2024 9:59:00 AM

Jubilant Pharmova Limited Share Price Information

24 hour Low and High

Low: 1193.1
High: 1233.4

All time High

9552.63

Price Change 1h

+₹-13.65 +-1.11%

Price Change 1d

+₹-13.65 +-1.11%

Price Change 1w

+₹44.70 +3.82%

Jubilant Pharmova Limited Market Information

Exchange

NSE

Market Cap

17931.33 Cr

About Jubilant Pharmova Limited Share

Jubilant Pharmova Limited operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally. It operates through six segments: Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research Development and Manufacturing Organisation; and Proprietary Novel Drugs. The Radiopharma segment offers radiopharmaceuticals products, which are used in the diagnosis and treatment of various diseases, including pulmonary embolism, cancer, coronary artery disease, and others. Its Allergy Immunotherapy segment provides specialised diagnostic devices for skin testing, as well as venom and allergy immunotherapy products. The Contract Development and Manufacturing Organisation - Sterile Injectables segment offers contract manufacturing services for sterile fill and finish injectables, liquids, ointments, creams, and ampoules. Its Generics segment engages in the development, manufacturing, distribution, sale, and marketing of generic formulations for therapeutic areas comprising cardiovascular system, central nervous system, gastrointestinal, antibiotics, and multispecialty. The Contract Research Development and Manufacturing Organisation segment offers drug discovery and development services and active pharmaceutical ingredients. The Proprietary Novel Drugs segment provides patient-focused biopharmaceutical services to address unmet medical needs in oncology and autoimmune diseases. It serves pharmaceutical, biotech, group purchasing organisations, allergists, and hospitals sectors. It sells its products through a network of dealers and distributors. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. The company was incorporated in 1978 and is based in Noida, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

5399

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Jubilant Pharmova (NSE:JUBLPHARMA) advances 8.1% this week, taking one-year gains to 157%
  • Jubilant Pharmova subsidiary gets VAI classification for Washington unit from USFDA, stock hits 52-week high
  • Jubilant Pharmova Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
  • Jubilant Pharmova Limited (NSE:JUBLPHARMA) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
  • Jubilant Pharmova Share Price Today - Jubilant Pharmova Stock Price Live NSE/BSE

FAQs